Alzheimer’s disease
This project focuses on how pathology spreads during disease progression, the link between amyloid-β (Aβ) and tau pathology, and down-stream mechanisms of Aβ- and tau toxicity.
RELATED PROJECTS
NHMRC Centre of Research Excellence in Cognitive Health
The Centre of Research Excellence in Cognitive Health focuses on the integrally linked areas of optimising cognitive health and the prevention of cognitive decline.
The centre aims to:
- Build the evidence base in cognitive health promotion and prevention of cognitive decline, focussing on evaluating putative new risks and under researched areas
- Develop methods of transferring, translating and implementing established findings, through the development and evaluation of interventions
- Model population level impacts of cognitive impairment and risk modification to quantify potential economic benefits of risk reduction and to inform policy.
The CRE Cognitive Health led by Professor Kaarin Anstey is a collaboration between Chief and Associate Investigators from the Australian National University, University of Melbourne, University of New South Wales, Australian Catholic University, Baker IDI Heart and Diabetes Institute and University of Exeter.
For more information about the CRE Cognitive Health, please visit the centre website, including more information on research themes, news and events, and recent publications.
The CRE Cognitive Health is funded by the National Health and Medical Research Council.
Genetics of early onset Alzheimer's disease
Dementia is usually thought of as a disease of ageing. However, the burden of young onset dementia, with symptoms occurring before age 65, has recently been identified as an important area not well supported by the health care system. Dr Bill Brooks has continued his development of information and support systems for use by families that have early onset hereditary dementias.